The provision of services accompanying technology-based electrophysiological-related interventions created an opportunity for health care professionals to specialize in the field of cardiac rhythm management.Known as Allied Professionals (APs), this diverse group of nurses, physician assistants, technologists, technicians, and engineers is dedicated to promoting excellence in the care of patients with cardiac rhythm disorders.
Search for "" returned 7 matches
November 2008 —This policy update revises the recommendations from the original statement published under the North American Society of Pacing and Electrophysiology (NASPE) in 2001. The current recommendations include revisions to criteria on billing and collection, assistance that should or should not be performed, and the proper supervision necessary.
March 2001 — The Ad Hoc NASPE/Industry Task Force developed this policy statement to clarify the role industry-employed allied professionals (IEAPs) should play in the clinical environment, with the objective of maintaining and improving high-quality and cost-effective care for patients with implanted cardiac rhythm devices.
August 15, 2016 - IHE is an initiative undertaken by healthcare professionals and industry to facilitate and strengthen the sharing of clinical data among health information technology (IT) systems. Systems developed in accordance with IHE communicate with one another more readily and completely, are easier to implement, and enable care providers to use information more effectively.
March 9, 2017 - Syncope has many causes and clinical presentations; the incidence depends on the population being evaluated. The purpose of this ACC/AHA/HRS guideline is to provide contemporary, accessible, and succinct guidance on the management of adult and pediatric patients with suspected syncope.
Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies23850
May 5, 2011 (Updated August 1, 2011) – Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for sudden death predisposing, genetic heart diseases in cardiology, which can be life-saving for some patients, the Heart Rhythm Society and the European Heart Rhythm Association have prepared HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies. The consensus statement was released at Heart Rhythm 2011, the Heart Rhythm Society’s 32nd Annual Scientific Sessions.
2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction30685
September 14, 2017 — The 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction, developed in collaboration with the ACC, AHA, APHRS, ASA, EHRA, IDSA, LAHRS, PACES, and STS, is intended to help clinicians in their decision-making process for managing leads and builds on the 2009 Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management document. It provides practical clinical guidance in the broad field of lead management, including lead extraction.
|The document features a clinician summary (an educational derivative product of the full document) and a pocket card, developed in partnership with Guideline Central and available across multiple platforms, including print, electronic media, and the Guideline Central mobile app. Visit www.guidelinecentral.com to access the pocket card.|